Speaker: Francis J. Miller, MD, Professor of Medicine, Dept. of Internal Medicine, Division of Cardiology, Duke University School of MedicineTopic: Role of Smooth Muscle Cell NADPH Oxidase in Vascular Disease Information from Dr. Miller on his lecture:The primary goal of my research program is to understand the molecular and cellular mechanisms that contribute to the … Continued
As the healthcare environment changes, patients increasingly see more personal control in their choice of doctors, therapies, and systems of care. From new models of tele-health to the ubiquitous direct-to-consumer pharmaceutical ads on TV, patients are shifting to a “customer mind-set” when they make health decisions and this has sweeping ramifications for healthcare providers. In … Continued
Speaker: Jeff Holmes, M.D., Ph.D.Professor of Biomedical Engineering & Medicine, University of VirginiaTopic: Scar Formation After Myocardial Infarction: What Happens, Why does it Matter, and What Can We Do about It?”
Lupus patients who previously needed to visit an infusion center to receive the drug Benlysta, now have the option to administer the medicine themselves at home using a novel “auto-injector” device, thanks in part to the efforts of Dr. Saira Sheikh, a UNC rheumatologist and allergist/immunologist who directs the lupus and clinical trials programs at the UNC Thurston Arthritis Research Center.
Roy Williams is entering his 15th season as head coach of the Tar Heels. He has achieved great success on the court, winning his third NCAA title in 2017, appearing in nine Final Fours (five with UNC) and earning eight Atlantic Coast Conference regular-season titles. Even greater is the impact he makes on the lives … Continued
Hepatitis C virus is a curable infectious disease, but treatment remains unavailable in resource-limited settings like the Democratic Republic of the Congo (DRC). The DRC Ministry of Health asked the University of North Carolina at Chapel Hill (UNC) to help determine the burden of infection and find a way to connect people infected with the virus to treatment. Using laboratory equipment readily available in developing countries, researchers from UNC and Abbott Diagnostics were able to define and map the burden of disease in the DRC. Their findings were published in Clinical Infectious Diseases.